aminolevulinic acid has been researched along with Actinic Reticuloid Syndrome in 36 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine pain intensity and its dependence upon various factors during PDT with 5-aminolevulinic acid for face/scalp AKs." | 9.17 | Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial. ( Buinauskaite, E; Buinauskiene, J; Valiukeviciene, S; Zalinkevicius, R, 2013) |
| "Topical 5-aminolevulinic acid-based photodynamic therapy (ALA-PDT) has been established in recent years as an effective treatment for disseminated actinic keratosis (AK)." | 9.11 | Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study. ( Blecha-Thalhammer, U; Hönigsmann, H; Kittler, H; Radakovic-Fijan, S; Tanew, A, 2005) |
| "Pain is the major drawback of photodynamic therapy (PDT), an otherwise effective treatment for actinic keratoses (AKs)." | 6.78 | Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial. ( Buinauskaite, E; Buinauskiene, J; Valiukeviciene, S; Zalinkevicius, R, 2013) |
| "Pain was independent of the patient's Fitzpatrick skin type, AK clinical grade, pretreatment fluorescence intensity, and the light dose during PDT." | 6.78 | Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial. ( Buinauskaite, E; Buinauskiene, J; Valiukeviciene, S; Zalinkevicius, R, 2013) |
| "Pain was assessed pre-illumination, during, and immediately after illumination, using a numeric rating scale." | 6.72 | Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-controlled study. ( Haedersdal, M; Philipsen, PA; Skiveren, J; Wiegell, SR; Wulf, HC, 2006) |
| "To determine pain intensity and its dependence upon various factors during PDT with 5-aminolevulinic acid for face/scalp AKs." | 5.17 | Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial. ( Buinauskaite, E; Buinauskiene, J; Valiukeviciene, S; Zalinkevicius, R, 2013) |
| "Topical 5-aminolevulinic acid-based photodynamic therapy (ALA-PDT) has been established in recent years as an effective treatment for disseminated actinic keratosis (AK)." | 5.11 | Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study. ( Blecha-Thalhammer, U; Hönigsmann, H; Kittler, H; Radakovic-Fijan, S; Tanew, A, 2005) |
| "Porphyria was induced in vivo in mice using 3,5-diethoxycarbonyl-1,4-dihydrocollidine or in vitro by exposing human liver Huh7 cells and keratinocytes, or their lysates, to protoporphyrin-IX, other porphyrins, or to δ-aminolevulinic acid plus deferoxamine." | 3.91 | Oxygen and Conformation Dependent Protein Oxidation and Aggregation by Porphyrins in Hepatocytes and Light-Exposed Cells. ( Basrur, V; Carter, EL; Herrmann, H; Lehnert, N; Maitra, D; Nesvizhskii, AI; Omary, MB; Osawa, Y; Ragsdale, SW; Richardson, R; Rittié, L; Wolf, MW; Zhang, H, 2019) |
| "Porphyrias are caused by porphyrin accumulation resulting from defects in the heme biosynthetic pathway that typically lead to photosensitivity and possible end-stage liver disease with an increased risk of hepatocellular carcinoma." | 3.91 | Oxygen and Conformation Dependent Protein Oxidation and Aggregation by Porphyrins in Hepatocytes and Light-Exposed Cells. ( Basrur, V; Carter, EL; Herrmann, H; Lehnert, N; Maitra, D; Nesvizhskii, AI; Omary, MB; Osawa, Y; Ragsdale, SW; Richardson, R; Rittié, L; Wolf, MW; Zhang, H, 2019) |
| "Pain is the major drawback of photodynamic therapy (PDT), an otherwise effective treatment for actinic keratoses (AKs)." | 2.78 | Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial. ( Buinauskaite, E; Buinauskiene, J; Valiukeviciene, S; Zalinkevicius, R, 2013) |
| "Pain was independent of the patient's Fitzpatrick skin type, AK clinical grade, pretreatment fluorescence intensity, and the light dose during PDT." | 2.78 | Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial. ( Buinauskaite, E; Buinauskiene, J; Valiukeviciene, S; Zalinkevicius, R, 2013) |
| "Pain was assessed using a visual analogue scale at 3, 6, 12 and 16 min." | 2.73 | Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. ( Collins, P; Moloney, FJ, 2007) |
| "Pain was assessed pre-illumination, during, and immediately after illumination, using a numeric rating scale." | 2.72 | Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-controlled study. ( Haedersdal, M; Philipsen, PA; Skiveren, J; Wiegell, SR; Wulf, HC, 2006) |
| "Actinic keratosis is currently believed to be an early stage in the evolution of squamous cell carcinoma." | 2.42 | Topical and light-based treatments for actinic keratoses. ( Alam, M; Goldberg, LH; Silapunt, S, 2003) |
| "As the first stage of squamous cell carcinoma, actinic keratosis is worthy of prompt evaluation and active treatment." | 2.42 | Topical and light-based treatments for actinic keratoses. ( Alam, M; Goldberg, LH; Silapunt, S, 2003) |
| "Porphyrias are caused by porphyrin accumulation resulting from defects in the heme biosynthetic pathway that typically lead to photosensitivity and possible end-stage liver disease with an increased risk of hepatocellular carcinoma." | 1.51 | Oxygen and Conformation Dependent Protein Oxidation and Aggregation by Porphyrins in Hepatocytes and Light-Exposed Cells. ( Basrur, V; Carter, EL; Herrmann, H; Lehnert, N; Maitra, D; Nesvizhskii, AI; Omary, MB; Osawa, Y; Ragsdale, SW; Richardson, R; Rittié, L; Wolf, MW; Zhang, H, 2019) |
| "Porphyria was induced in vivo in mice using 3,5-diethoxycarbonyl-1,4-dihydrocollidine or in vitro by exposing human liver Huh7 cells and keratinocytes, or their lysates, to protoporphyrin-IX, other porphyrins, or to δ-aminolevulinic acid plus deferoxamine." | 1.51 | Oxygen and Conformation Dependent Protein Oxidation and Aggregation by Porphyrins in Hepatocytes and Light-Exposed Cells. ( Basrur, V; Carter, EL; Herrmann, H; Lehnert, N; Maitra, D; Nesvizhskii, AI; Omary, MB; Osawa, Y; Ragsdale, SW; Richardson, R; Rittié, L; Wolf, MW; Zhang, H, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.78) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 26 (72.22) | 29.6817 |
| 2010's | 9 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Radakovic, S | 1 |
| Tanew, A | 2 |
| Katz, S | 1 |
| Backeris, P | 1 |
| Merck, C | 1 |
| Suprun, M | 1 |
| D'Souza, S | 1 |
| Bishop, DF | 1 |
| Desnick, RJ | 1 |
| Moore, K | 1 |
| Ubarretxena-Belandia, I | 1 |
| Lemischka, IR | 1 |
| Maitra, D | 1 |
| Carter, EL | 1 |
| Richardson, R | 1 |
| Rittié, L | 1 |
| Basrur, V | 1 |
| Zhang, H | 1 |
| Nesvizhskii, AI | 1 |
| Osawa, Y | 1 |
| Wolf, MW | 1 |
| Ragsdale, SW | 1 |
| Lehnert, N | 1 |
| Herrmann, H | 1 |
| Omary, MB | 1 |
| Buinauskaite, E | 1 |
| Zalinkevicius, R | 1 |
| Buinauskiene, J | 1 |
| Valiukeviciene, S | 1 |
| Petersen, B | 1 |
| Wiegell, SR | 2 |
| Wulf, HC | 3 |
| Togsverd-Bo, K | 1 |
| Lei, U | 1 |
| Erlendsson, AM | 1 |
| Taudorf, EH | 1 |
| Philipsen, PA | 2 |
| Skov, L | 1 |
| Hædersdal, M | 1 |
| Honorato-Cia, C | 1 |
| Martinez-Simón, A | 1 |
| Cacho-Asenjo, E | 1 |
| Guillén-Grima, F | 1 |
| Tejada-Solís, S | 1 |
| Diez-Valle, R | 1 |
| Xia, Y | 1 |
| Huang, Y | 1 |
| Lin, L | 1 |
| Liu, X | 1 |
| Jiang, S | 1 |
| Xiong, L | 1 |
| Juzenas, P | 1 |
| Juzeniene, A | 1 |
| Wang, X | 1 |
| Wang, H | 1 |
| Huang, Z | 1 |
| Goldman, M | 1 |
| Atkin, D | 1 |
| Kirveliene, V | 1 |
| Sadauskaite, A | 1 |
| Kadziauskas, J | 1 |
| Sasnauskiene, S | 1 |
| Juodka, B | 1 |
| Silapunt, S | 1 |
| Goldberg, LH | 1 |
| Alam, M | 1 |
| Dragieva, G | 2 |
| Hafner, J | 2 |
| Dummer, R | 2 |
| Schmid-Grendelmeier, P | 1 |
| Roos, M | 1 |
| Prinz, BM | 2 |
| Burg, G | 2 |
| Binswanger, U | 2 |
| Kempf, W | 2 |
| Ericson, MB | 1 |
| Sandberg, C | 1 |
| Stenquist, B | 1 |
| Gudmundson, F | 1 |
| Karlsson, M | 1 |
| Ros, AM | 1 |
| Rosén, A | 1 |
| Larkö, O | 1 |
| Wennberg, AM | 2 |
| Rosdahl, I | 1 |
| Radakovic-Fijan, S | 1 |
| Blecha-Thalhammer, U | 1 |
| Kittler, H | 1 |
| Hönigsmann, H | 1 |
| Kreutzer, K | 1 |
| Bonnekoh, B | 2 |
| Franke, I | 1 |
| Gollnick, H | 2 |
| Yokoyama, S | 1 |
| Nakano, H | 1 |
| Nishizawa, A | 1 |
| Kaneko, T | 1 |
| Harada, K | 1 |
| Hanada, K | 1 |
| Breuninger, H | 1 |
| Gilaberte, Y | 1 |
| Serra-Guillén, C | 1 |
| de las Heras, ME | 1 |
| Ruiz-Rodríguez, R | 1 |
| Fernández-Lorente, M | 1 |
| Benvenuto-Andrade, C | 1 |
| González-Rodríguez, S | 1 |
| Guillén-Barona, C | 1 |
| Gold, MH | 1 |
| Bradshaw, VL | 1 |
| Boring, MM | 1 |
| Bridges, TM | 1 |
| Biron, JA | 1 |
| Skiveren, J | 1 |
| Haedersdal, M | 1 |
| Morton, C | 1 |
| Campbell, S | 1 |
| Gupta, G | 1 |
| Keohane, S | 1 |
| Lear, J | 1 |
| Zaki, I | 1 |
| Walton, S | 1 |
| Kerrouche, N | 1 |
| Thomas, G | 1 |
| Soto, P | 1 |
| Braathen, LR | 1 |
| Szeimies, RM | 3 |
| Basset-Seguin, N | 1 |
| Bissonnette, R | 1 |
| Foley, P | 1 |
| Pariser, D | 1 |
| Roelandts, R | 1 |
| Morton, CA | 1 |
| Kerr, AC | 1 |
| Ferguson, J | 1 |
| Ibbotson, SH | 1 |
| Moloney, FJ | 1 |
| Collins, P | 1 |
| Hauschild, A | 1 |
| Babilas, P | 1 |
| Travnik, R | 1 |
| Werner, A | 1 |
| Landthaler, M | 1 |
| Tadiparthi, S | 1 |
| Falder, S | 1 |
| Saour, S | 1 |
| Hills, SJ | 1 |
| Liew, S | 1 |
| Romeo, G | 1 |
| Ladner, DP | 1 |
| Klein, SD | 1 |
| Steiner, RA | 1 |
| Walt, H | 1 |
| Cerburkovas, O | 1 |
| Krause, M | 1 |
| Ulrich, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Effect of Photodynamic Treatment When Treating Actinic Keratoses With Different Light Doses[NCT01541228] | 38 participants (Actual) | Interventional | 2010-04-30 | Completed | |||
| A Randomized Half-side Comparative Trial of Fractional Laser-assisted Daylight Photodynamic Therapy Versus Daylight Photodynamic Therapy in Organ Transplant Recipients With Multiple Actinic Keratoses of the Scalp or Forehead[NCT01898936] | 12 participants (Actual) | Interventional | 2013-08-31 | Completed | |||
| Topical Imiquimod 5% Cream Therapy Versus Photodynamic Therapy With Methyl-aminolaevulinate 16% Cream of Actinic Keratoses in Organ Transplant Recipients[NCT01538901] | Phase 4 | 10 participants (Actual) | Interventional | 2012-09-30 | Terminated (stopped due to prolonged recruitment phase) | ||
| Evaluation of the Formulation of 5-aminolevulinic Acid With Dimethylsulfoxide in Photodynamic Therapy for Treatment of Actinic Keratosis[NCT01459393] | Phase 3 | 137 participants (Actual) | Interventional | 2010-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for aminolevulinic acid and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Topical and light-based treatments for actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Antineoplasti | 2003 |
[Photodynamic therapy in dermatology].
Topics: Aminolevulinic Acid; Esthetics; Forecasting; Humans; Infrared Rays; Low-Level Light Therapy; Photoch | 2006 |
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.
Topics: Aminolevulinic Acid; Australia; Basal Cell Nevus Syndrome; Bowen's Disease; Carcinoma, Basal Cell; C | 2007 |
The hepatic porphyrias.
Topics: 5-Aminolevulinate Synthetase; Acute Disease; Adolescent; Adult; Aminolevulinic Acid; Chemical Phenom | 1980 |
13 trials available for aminolevulinic acid and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial.
Topics: Aged; Aminolevulinic Acid; Animals; Face; Female; Humans; Male; Pain; Pain Measurement; Photochemoth | 2013 |
Light protection of the skin after photodynamic therapy reduces inflammation: an unblinded randomized controlled study.
Topics: Aminolevulinic Acid; Drug Eruptions; Erythema; Female; Fluorescence; Humans; Keratosis, Actinic; Mal | 2014 |
Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial.
Topics: Aged; Aminolevulinic Acid; Combined Modality Therapy; Female; Humans; Keratosis, Actinic; Laser Ther | 2015 |
Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients.
Topics: Administration, Topical; Adult; Aged; Aminolevulinic Acid; Bowen's Disease; Case-Control Studies; Fe | 2004 |
A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients.
Topics: Adult; Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Follow-Up Studies; Heart Transplant | 2004 |
A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients.
Topics: Adult; Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Follow-Up Studies; Heart Transplant | 2004 |
A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients.
Topics: Adult; Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Follow-Up Studies; Heart Transplant | 2004 |
A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients.
Topics: Adult; Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Follow-Up Studies; Heart Transplant | 2004 |
Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome.
Topics: Aged; Aminolevulinic Acid; Dose-Response Relationship, Radiation; Female; Humans; Keratosis; Male; M | 2004 |
Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study.
Topics: Aminolevulinic Acid; Female; Humans; Keratosis; Male; Photochemotherapy; Photosensitivity Disorders; | 2005 |
[Photodynamic therapy with methylaminooxopentanoate (Metvix) and a broad band light source (PhotoDyn 501): practical experiences in problem-patients with actinic keratoses and basal cell carcinomas].
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Keratosis; Ligh | 2004 |
Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage.
Topics: Adult; Aminolevulinic Acid; Facial Dermatoses; Female; Follow-Up Studies; Humans; Male; Middle Aged; | 2006 |
Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Double-Blind Method; Gel | 2006 |
Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Cryosurgery; Esthetics; Facial Dermatoses; Female; Hum | 2006 |
Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminolevulinic Acid; Double-Blind Method; Humans; | 2007 |
Split-face-study using two different light sources for topical PDT of actinic keratoses:non-inferiority of the LED system.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Keratosis; Li | 2008 |
19 other studies available for aminolevulinic acid and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
5-aminolaevulinic acid patch-photodynamic therapy in the treatment of actinic cheilitis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Cheilitis; Female; Follow-Up Studies; Humans; Male; Mi | 2017 |
Design and validation of an open-source modular Microplate Photoirradiation System for high-throughput photobiology experiments.
Topics: Aminolevulinic Acid; Computer Graphics; Humans; Light; Photobiology; Photobleaching; Photochemothera | 2018 |
Oxygen and Conformation Dependent Protein Oxidation and Aggregation by Porphyrins in Hepatocytes and Light-Exposed Cells.
Topics: Aminolevulinic Acid; Animals; Carcinoma, Hepatocellular; Cell Line; Deferoxamine; Heme; Hepatocytes; | 2019 |
Safety Profile of 5-Aminolevulinic Acid as a Surgical Adjunct in Clinical Practice: A Review of 207 Cases From 2008 to 2013.
Topics: Adult; Aged; Aminolevulinic Acid; Anemia; Anesthesia; Blood Loss, Surgical; Blood Transfusion; Brain | 2015 |
Drug-induced photosensitivity.
Topics: Aminolevulinic Acid; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Ca | 2009 |
A comparative study on the enhancement efficacy of specific and non-specific iron chelators for protoporphyrin IX production and photosensitization in HaCat cells.
Topics: Aminolevulinic Acid; Cell Line, Transformed; Deferoxamine; Edetic Acid; Humans; Iron Chelating Agent | 2009 |
Reduction of cutaneous photosensitivity by application of ointment containing ferrous or cobaltous ions concomitant with the use of topical protoporphyrin IX precursors.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Animals; Cobalt; Female; Ferrous Compounds; Mice; Mi | 2010 |
Photosensitization induced by exposure to colour cathode ray tube monitor following topical 5-aminolaevulinic acid-based photodynamic therapy: a case report.
Topics: Acne Vulgaris; Administration, Topical; Adult; Aminolevulinic Acid; Cathode Ray Tube; Computer Termi | 2010 |
ALA/PDT in the treatment of actinic keratosis: spot versus confluent therapy.
Topics: Adult; Aged; Aminolevulinic Acid; Face; Female; Humans; Keratosis; Male; Middle Aged; Photochemother | 2003 |
Correlation of death modes of photosensitized cells with intracellular ATP concentration.
Topics: Adenosine Triphosphate; Aminolevulinic Acid; Animals; Apoptosis; Carcinoma, Hepatocellular; Glycolys | 2003 |
A case of photocontact urticaria induced by photodynamic therapy with topical 5-aminolaevulinic acid.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Female; Humans; Mycosis Fungoides; Photochemothe | 2005 |
[Reader's letter concerning K. Kreutzer, B.Bonnekoh, I. Franke, H. Gollnick. Photodynamic therapy with methylaminooxopentanoate (Metvix) and a broad band light source (Photdyn 501): practical experiences in problem patients with actinic keratoses and basa
Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Humans; Keratosis; Photochemotherapy; Photosensitivity D | 2005 |
Acute phototoxicity with urticarial features during topical 5-aminolaevulinic acid photodynamic therapy.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Humans; Male; Middle Aged; Photochemotherapy; Photos | 2007 |
[EADV-Conference 16.-20.05.2007 in Vienna: Study of new pharmaceuticals 5-ALAPlaster (PD P 506 A)]].
Topics: Aminolevulinic Acid; Austria; Bandages; Clinical Trials as Topic; Photochemotherapy; Photosensitivit | 2007 |
Intense pulsed light with methyl-aminolevulinic acid for the treatment of actinic keratoses.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Humans; Photochemotherapy; Photosensitivity Disorders; | 2008 |
New treatment for actinic keratosis.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Photochemotherapy; Photosensitivity Disorders; Photo | 2000 |
Synergistic toxicity of delta-aminolaevulinic acid-induced protoporphyrin IX used for photodiagnosis and hypericum extract, a herbal antidepressant.
Topics: Aminolevulinic Acid; Drug Eruptions; Drug Synergism; Female; Humans; Hypericum; Middle Aged; Photose | 2001 |
[Disseminated actinic keratoses. Comparison of topical photodynamic therapy with 5-aminolevulinic acid and topical 5% imiquimod cream].
Topics: Adjuvants, Immunologic; Aged; Aminolevulinic Acid; Aminoquinolines; Female; Follow-Up Studies; Human | 2001 |
New treatments for actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Cryosurgery; | 2002 |